Hyperhomocysteinemia: an important risk factor for cardiovascular disease? Not yet!
Berger
P
P
Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA. berger.peter@mayo.edu
D002318:Cardiovascular Diseases / Q000209:etiology*; D002986:Clinical Trials as Topic / Q000592:standards; D006801:Humans; D020138:Hyperhomocysteinemia / Q000150:complications* / Q000188:drug therapy; D012307:Risk Factors; D016896:Treatment Outcome